Pages that link to "Q40814855"
Jump to navigation
Jump to search
The following pages link to Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo (Q40814855):
Displaying 50 items.
- PINP: a new method of tagging neuronal populations for identification during in vivo electrophysiological recording (Q21562431) (← links)
- Herpes simplex virus ICP27 protein directly interacts with the nuclear pore complex through Nup62, inhibiting host nucleocytoplasmic transport pathways (Q24305296) (← links)
- Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexes (Q24607261) (← links)
- Neuroanatomy goes viral! (Q26802140) (← links)
- Axonal transport of AAV9 in nonhuman primate brain. (Q27323331) (← links)
- Corticostriatal neurons in auditory cortex drive decisions during auditory discrimination (Q30446866) (← links)
- Cytomegalovirus replicon-based regulation of gene expression in vitro and in vivo (Q31063997) (← links)
- Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons (Q33822237) (← links)
- DNA repair proteins affect the lifecycle of herpes simplex virus 1. (Q33936284) (← links)
- Long-term Cre-mediated retrograde tagging of neurons using a novel recombinant pseudorabies virus (Q34127093) (← links)
- Visualization of cortical projection neurons with retrograde TET-off lentiviral vector (Q34446974) (← links)
- Problems in the use of herpes simplex virus as a vector (Q35216652) (← links)
- Herpes simplex virus vectors for Parkinson's disease (Q35216671) (← links)
- Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity. (Q35280041) (← links)
- Viral vector-mediated gene transfer of neurotrophins to promote regeneration of the injured spinal cord. (Q35618384) (← links)
- Gene-based therapy in prostate cancer (Q35853023) (← links)
- Herpes simplex virus-based vectors (Q35863367) (← links)
- HSV trafficking and development of gene therapy vectors with applications in the nervous system (Q36134871) (← links)
- Versatility of gene therapy vectors through viruses (Q36150489) (← links)
- Gene therapy for the treatment of sensory neuropathy (Q36446943) (← links)
- Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception (Q36634794) (← links)
- Transduction of brain by herpes simplex virus vectors (Q36681937) (← links)
- Gene therapy for the treatment of diabetic neuropathy (Q37319721) (← links)
- Delivery of RNA interference triggers to sensory neurons in vivo using herpes simplex virus (Q37737316) (← links)
- Optogenetics: potentials for addiction research (Q37935104) (← links)
- Viral vectors for gene delivery to the central nervous system (Q37946113) (← links)
- Gene therapy: a potential approach for cancer pain (Q38745962) (← links)
- Replication-defective HSV-1 effectively targets trigeminal ganglion and inhibits viral pathopoiesis by mediating interferon gamma expression in SH-SY5Y cells (Q39042425) (← links)
- Defining nervous system susceptibility during acute and latent herpes simplex virus-1 infection. (Q39182595) (← links)
- The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway (Q39682246) (← links)
- A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV (Q39683145) (← links)
- Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapy (Q39732678) (← links)
- Efficient delivery of RNA Interference to peripheral neurons in vivo using herpes simplex virus (Q39967822) (← links)
- Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome (Q40146699) (← links)
- Impaired axonal regeneration by isolectin B4-binding dorsal root ganglion neurons in vitro. (Q40176541) (← links)
- Neuroprotective effects of virally delivered HSPs in experimental stroke (Q40389152) (← links)
- Herpes simplex virus type 1 infection induces the stabilization of p53 in a USP7- and ATM-independent manner (Q40535811) (← links)
- Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids (Q40585361) (← links)
- Functional expression of ATM gene carried by HSV amplicon vector in vitro and in vivo (Q40606308) (← links)
- Optimisation of herpes simplex virus-based vectors for delivery to human peripheral blood mononuclear cells (Q40697539) (← links)
- A Cre-dependent, anterograde transsynaptic viral tracer for mapping output pathways of genetically marked neurons (Q40950555) (← links)
- RNA interference with special reference to combating viruses of crustacea (Q42272671) (← links)
- The functional properties of barrel cortex neurons projecting to the primary motor cortex (Q43119662) (← links)
- Modified herpes simplex virus delivery of enhanced GFP into the central nervous system. (Q43889605) (← links)
- Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis. (Q43986704) (← links)
- Heat shock protein 27 delivered via a herpes simplex virus vector can protect neurons of the hippocampus against kainic-acid-induced cell loss (Q44005958) (← links)
- Widespread correction of lysosomal storage in the mucopolysaccharidosis type VII mouse brain with a herpes simplex virus type 1 vector expressing beta-glucuronidase (Q45419203) (← links)
- Stable levels of long-term transgene expression driven by the latency-associated transcript promoter in a herpes simplex virus type 1 vector (Q45424362) (← links)
- Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system (Q45456081) (← links)
- Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons. (Q45867838) (← links)